Wegovy (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership.

In patients with COVID-19, preexisting immunity and Omicron infection were associated with reduced disease severity and upper respiratory symptom presentation.

Counseling was the most common smoking cessation service at US behavioral health centers in 2023, and pharmacotherapy was offered at less than half.